About SK:
SK Life Science, Inc., the U.S. subsidiary of SK Biopharmaceuticals, is an innovative global pharmaceutical company focused on the research, development and treatment of central nervous system (CNS) disorders. The company has a pipeline of eight compounds in development for CNS disorders. For more information about SK life science, please visit us at, sklifescienceinc.com .
In 2020, SK life science received FDA approval for XCOPRI® (cenobamate tablets) CV.
For more information about XCOPRI®, please visit xcopri.com .
CONNECT WITH SK LIFE SCIENCE, INC.
Latest Sponsored Posts
Jason’s Story: Turning Empathy Into Action While Living With Epilepsy
For Jason Raether, his epilepsy diagnosis only deepened his empathy and strengthened his commitment to educating those around him.… Read More
Living with epilepsy is a journey full of unknowns. For Shannon, a father from Louisiana, those unknowns brought fear, loss of independence, and emotional challenges. But through resilience, advocacy, and support, he’s found hope and a new path forward.… Read More
Finding Strength on the “Road to Reduction”
Living with an epilepsy diagnosis means facing a road to reduction of seizures that’s rarely straight or smooth.… Read More